CJC-1295 (No DAC)

CJC-1295 (No DAC)

$50.00

CJC-1295 (No DAC) is an investigational research peptide studied for GHRH receptor signaling and short-acting growth hormone–axis dynamics. Commonly explored in research focused on pulsatile GH release patterns and downstream biomarkers (including IGF-1, model-dependent). For laboratory research use only. Not for human or veterinary use. Protocols are typically approached low and slow (conservative titration) for cleaner data.

17 in stock

Categories: , Tags: , ,

CJC-1295 (No DAC) – 5MG — Premium Research Peptide (Laboratory Use Only)

CJC-1295 (No DAC) is a widely used research chemical selected for laboratory studies investigating growth hormone–axis signaling. As a short-acting GHRH analog (without DAC), it’s commonly used in research designs where investigators want to examine pulsatile signaling behavior, time-course effects, and downstream biomarker changes under controlled conditions.

Research Use Only: Not intended for human consumption. Not for diagnostic, therapeutic, or clinical use. Not for veterinary use.

Why researchers choose it

  • Studied for GHRH receptor activity linked to growth hormone–axis signaling

  • Useful for experiments tracking pulsatile dynamics and time-dependent responses

  • Often included in protocols monitoring downstream biomarkers (e.g., IGF-1, depending on model/design)

  • Popular for researchers who prefer short-duration signaling compared with longer-acting variants

How it works (Research focus)

In research contexts, CJC-1295 (No DAC) is investigated for its ability to:

  • Engage GHRH signaling, which can influence endogenous GH release patterns in study models

  • Support structured evaluation of dose timing vs biomarker response in controlled experiments

  • Provide a tool for comparing GHRH-pathway modulation across different study designs

Related products